test

A Single-arm, Multicenter, Proof-of-Concept Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects with Elevated Serum Calcium Despite Recent Treatment with IV Bisphosphonates

Conditions

Hypercalcemia

Trial Phase

Trial Purpose and Description

Trial Purpose


Participation Guidelines

Age:
18 Years and older
Gender:
Both

Eligibility Criteria

Sponsor:
Amgen, Inc
Dates:
February 2010
Last Updated:
Study HIC#:
0908005536